CYP11B1-IN-1 is a selective, orally active hCYP11B1 inhibitor, with an IC 50 of 2 nM against hCYP11B1 and an IC 50 of 1.8 μM against rat CYP11B1 . CYP11B1-IN-1 can be used for the research of Cushing's disease.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Cytochrome P450
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.